Journals / Türkiye Acil Tıp Dergisi / 2006 / Cilt: 6 - Sayı: 3

An analysis of bleeding complications related to warfarin in the emergency department

Acil serviste varfarin kullanımına bağlı kanama komplikasyonlarının incelenmesi

Pages
117–121
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Frequency both of hemorrhage and administration of vitamin K in our hospital are higher than the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Bleeding is the most frequent complication of the anticoagulant agents.
📊
Key Findings & Data:Materials and Methods: This study was a retrospective chart review of adult patients who were admittance to ED and those with have ordered International Normalized Ratio (INR) profile between December 2005 and May 2006.
💡
Conclusion & Impact:Conclusion: Frequency both of hemorrhage and administration of vitamin K in our hospital are higher than the literature.
🔬Design:Review & Systematic Survey
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Bleeding is the most frequent complication of the anticoagulant agents. Although bleeding com­plications are well-documented in the literature, our country data have been rarely reported. Description of demographic and clinical characteristics in the patients with bleeding related to the warfarin is purposed in our study on the emergency department. Materials and Methods: This study was a retrospective chart review of adult patients who were admittance to ED and those with have ordered International Normalized Ratio (INR) profile between December 2005 and May 2006. Warfarin overdose was defined as the INR ratio >4. Patients with hemorrhage related to warfarin overdose was defined as the first group and patients with hemorrhage without warfarin overdose was defined as the second group in patients with warfarin treatment. Clinical findings, hospitalization and discharging fea­tures were analyzed by using SPSS software. Results: Warfarin overdose was determined in 28 (33.6%) patients in total 120 patients on warfarin treatment. There were 14 (11.6%) patients in the first group and 22 (18.3%) patients in the second group. Coronary artery disease was the most common comorbid condition and atrial fibrillation was the most frequent anticoagulant indication in both groups. It was determined that gastrointestinal bleeding and intracranial hemorrhage are the most common hemorrhage complications in the first group and hematuria is the most common complication in the second group. Vitamin K treatment was administered 28.6% of all patients with warfarin overdose, 50% of patients with first group, and 4.5% of the second group. Majority of patients of both groups were discharged from the emergency department. Only two mortality (1.6%) we're determined due to warfarin overdose. Conclusion: Frequency both of hemorrhage and administration of vitamin K in our hospital are higher than the literature.

Özet

Giriş: Antikoagülan ajan kullanımına bağlı en önemli komplikasyon kanamadır. Dünya literatüründe bu konu ile ilgili veriler bulunmakla birlikte ülkemiz verileri kısıtlıdır. Çalışmamızın amacı, acil serviste varfarine bağlı kanaması olan has­taların demografik ve klinik özelliklerini tanımlamaktır. Gereç ve Yöntem: 2005-Mayıs 2006 tarihleri arasında acil servise başvurup, 'International Normalized Ratio' (INR) profili istenen tüm erişkin hastaların dosyaları incelendi. Varfarin kullanıp aşırı antikoagülasyonu olma duru­mu INR değeri >4 olarak tanımlandı. Varfarin kullanan, aşırı antikoagülasyon ile birlikte kanama komplikasyonu bulunan hastalar birinci grup, varfarin kullanan ancak aşırı antikoagülasyonu olmadan kanaması olan hastalar ikin­ci grup olarak sınıflandırıldı. Hastaların klinik bulguları, hastaneye yatış ve taburculuk özellikleri SPSS 11.0 progra­mı kullanılarak analiz edildi. Bulgular: Varfarin kullanan 120 hastadan 28'inde (%33.6) aşırı antikoagülasyon bulundu. Birincf gruptaki hasta sayısı 14 (%11.6), ikinci gruptaki hasta sayısı ise 22 (%18.3) idi. Birinci ve ikinci grupta en sık görülen komorbid hastalık koroner arter hastalığı ve en sık antikoagülasyon endikasyonu atriyal fibrilasyon idi. Birinci grup hastalar­da gastrointestinal ve intrakraniyal kanama, ikinci grup hastalarda ise hematüri en sık görülen kanama komplikas­yonu idi. Aşırı antikoagülasyonu olan tüm hastaların %28.6'sına, birinci grup hastaların %50'sine, ikinci grup has­taların ise %4.5'ine K vitamini verildiği görüldü. Birinci ve ikinci gruptaki hastaların çoğunluğunun acil servisten ta­burcu edildiği saptandı. Varfarin kullanan tüm hastalar içinde sadece iki hastada varfarin aşırı dozuna bağlı olarak ölüm saptanmıştır (%1.6). Sonuç: Hastanemizde, varfarine bağlı kanama oranımız ve K vitamini uygulama oranımız literatüre göre daha yük­sektir.

🔖

Cite This Article

DEMİR, E., PEYNİRCİ, H., CANBAY, C., DAĞ, T., KAYA, A., YANTURALI, S., ÜNVERİR, P. (2022). An analysis of bleeding complications related to warfarin in the emergency department. Türkiye Acil Tıp Dergisi, Cilt: 6 - Sayı: 3, 117–121. https://ajindex.com/articles/626188

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hambleton J. Drugs used in disorders of coaguation. In: Katzung BG, editor. Basic and clinical pharmacology. A LANGE medical book. McGraw-Hill
  2. p. 543-60. 2.Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Strieker BH. The risk of overanticoagulation in patients with heart failure on coumarin anticoagu­ lants. Br J Haematol 2004
  3. Koo S, Kucher N, Nguyen PL, Fanikos J, Marks PW, Goldhaber SZ. The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med 2004
  4. Brigden ML, Kay C, Le A, Graydon C, McLeod B. Audit of the frequency and clin­ ical response to excessive oral anticoagulation in an out-patient population. Am J Hematol 1998
  5. Hylek EM, Chang YC, Skates S J, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 2000
  6. Koo S, Kucher N, Nguyen PL, et al. The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med 2004
  7. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993
  8. Garcia DA, Regan S, Crowther M, Hylek EM. The risk of hemorrhage among patients with warfarin-associated coagulopathy. J Am Coll Cardiol 2006
  9. Denizbaşı A, Unluer E, Güneysel O, et al. Complications of warfarin therapy and the correlation of the outcomes with INR levels.J Emerg Med 2006
  10. [Abstract] 10.Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ. Major bleeding complications in a specialized anticoagulation service. Am J Cardiol 2005
  11. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complica­tions in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993
  12. Glover JJ, Morrill GB. Conservative treatment of overanticoagulated patients. Chest 1995
  13. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 2000
  14. Weber JE, Charles MJ, Pollack V. Anticoagulants, antiplatelet agents and fibrinolytics. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency medicine a comprehensive study guide. 6th ed. New York: